Recombinant activated factor VII in the treatment of intractable non-surgical bleeding following major vascular procedures | Zendy

Igor Končar | Zendy; Nebojša Savić | Zendy; Lazar Davidović | Zendy; Dušica Simić | Zendy; Dejan Marković | Zendy; Radomir Sindjelić | Zendy

Open Access

Recombinant activated factor VII in the treatment of intractable non-surgical bleeding following major vascular procedures

Author(s) -

Igor Končar,

Nebojša Savić,

Lazar Davidović,

Dušica Simić,

Dejan Marković,

Radomir Sindjelić

Publication year - 2008

Publication title -

srpski arhiv za celokupno lekarstvo

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.135

H-Index - 17

eISSN - 2406-0895

pISSN - 0370-8179

DOI - 10.2298/sarh0808367k

Subject(s) - medicine , surgery , inferior vena cava , abdominal aorta , aorta , abdominal aortic aneurysm , anesthesia , aneurysm

A recombinant form of activated factor VII (rFVIIa) is a haemostatic drug that is approved for use in haemophiliacs with antibodies to factor VIII or factor IX. Most recent studies and clinical experience have shown that rFVIIa (NovoSeven, Novo Nordisk A/S, Denmark) gives extreme haemostatic effect in patients with severe "non-haemophilic" bleeding produced after trauma and major surgery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research